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Acetylation of histone and nonhistone proteins is an
important posttranslational modification affecting
many cellular processes. Here, we report that NuA4
acetylation of Sip2, a regulatory b subunit of the
Snf1 complex (yeast AMP-activated protein kinase),
decreases as cells age. Sip2 acetylation, controlled
by antagonizing NuA4 acetyltransferase and Rpd3
deacetylase, enhances interaction with Snf1, the
catalytic subunit of Snf1 complex. Sip2-Snf1 interac-
tion inhibits Snf1 activity, thus decreasing phosphor-
ylation of a downstream target, Sch9 (homolog of
Akt/S6K), and ultimately leading to slower growth
but extended replicative life span. Sip2 acetylation
mimetics are more resistant to oxidative stress. We
further demonstrate that the anti-aging effect of
Sip2 acetylation is independent of extrinsic nutrient
availability and TORC1 activity.We propose a protein
acetylation-phosphorylation cascade that regulates
Sch9 activity, controls intrinsic aging, and extends
replicative life span in yeast.
INTRODUCTION
Reversible acetylation and deacetylation of histones are impor-
tant in regulating chromatin structure and controlling transcrip-
tion of genes that are crucial for maintenance of cell viability
(Lin et al., 2008). Among the histone deacetylases, Sir2 (yeast
homolog of mammalian SIRT1; Donmez and Guarente, 2010)and Rpd3 (yeast homolog ofmammalian HDAC1;Willis-Martinez
et al., 2010) are especially important in life span regulation in
yeast (Chang and Min, 2002; Jiang et al., 2002). Sir2 extends
replicative life span partially via deacetylating histone H4 lysine
16 that compromises transcriptional silencing (Dang et al.,
2009; Imai et al., 2000; Sinclair and Guarente, 1997). However,
the life span discrepancies between substrate histone mutants
and the acetyltransferase/deacetylase mutants (Dang et al.,
2009) suggest possible roles of nonhistone acetylation sub-
strates in mediating life span regulation by these (de)acetylating
enzymes.
Inapreviousstudy,we identifiedmanynonhistonesubstratesof
theNuA4 complex, ofwhich the catalytic subunit, Esa1, is the only
essential histone acetyltransferase in yeast (Lin et al., 2009). We
show here that NuA4 catalytic mutants have replicative life span
defects caused by impaired acetylation of Sip2, a known replica-
tive life span regulator (Ashrafi et al., 2000). Sip2 is one of three
b regulatory subunits of the Snf1 complex and the only b subunit
implicated in yeast replicative aging (Ashrafi et al., 2000; Lin
et al., 2003). The Snf1 complex contains (1) a catalytic a subunit,
Snf1, which is an AMP-activated serine/threonine protein kinase,
(2) a g subunit, Snf4, (3) and one of the three b regulatory sub-
units—Sip1, Sip2, or Gal83—each with a distinctive substrate
specificity (Schmidt and McCartney, 2000). In addition to being
required for transcription of glucose-repressed genes and utiliza-
tion of carbon sources other than glucose (Amodeo et al., 2007),
Snf1 is also a key player in the response to cellular stress (Sanz,
2003). Importantly, Snf1 activity increases in aged cells even
when ambient glucose is abundant (Ashrafi et al., 2000; Hed-
backer and Carlson, 2008). Null mutations in SIP2, the SNF1
repressor, decrease life span; these can be rescued by deletion
of SNF4, the SNF1 activator (Guarente and Kenyon, 2000).Cell 146, 969–979, September 16, 2011 ª2011 Elsevier Inc. 969
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Figure 1. Sip2 Is Acetylated at Four Lysine Sites by Esa1, and Rpd3 Is the Counteracting Deacetylase
(A) Cartoon of Sip2 structural domains (adapted from Hedbacker and Carlson, 2008). Mass spectrometry identified four acetylated lysine residues of Sip2, K12,
K16, K17, and K256. Numbers indicate amino acid residues. (Vertical straight line) Myristoylation site; (downward arrows) acetylation sites; (right-left arrow)
regions mapped as sufficient for Snf1 interaction by deletion analysis (Amodeo et al., 2007). Ac, acetylation; N-Myr, N-myristoylation; GBD, glycogen-binding
domain.
(B) Chromosomally integrated sip2-3KR and sip2-4KR, but not sip2-G2A, mutants are hypoacetylated in vivo. The sip2-G2A mutant blocks myristoylation.
sip2-3KR, sip2-K12/16/17R; sip2-4KR, sip2-K12/16/17/256R.
(C) Rpd3, but not Hda1, removes Sip2 acetylation in vitro. Deacetylation reaction is inhibited by addition of trichostatin A (TSA). Asterisk indicates Hda1-TAP;
arrowhead indicates Rpd3-TAP.
(D) Sip2 is hypoacetylated in strains carrying the Ts allele of ESA1, esa1-531, but is hyperacetylated in rpd3D; deletion of RPD3 rescues the acetylation defect of
esa1-531.
(E) Increased Sip2 acetylation in rpd3D is blocked when lysines are mutated to arginines.
See also Figure S1 and Figure S2.Here, we report that Sip2 acetylation is controlled by the NuA4
and its counteracting deacetylase, Rpd3 (Chang and Pillus,
2009). We examined replicative life span in various SIP2 acetyla-
tion mutants and found that Sip2 acetylation extends yeast life
span; besides, constitutive Sip2 acetylation mimetics nearly
totally rescue the life span-shortening phenotype of the NuA4
catalytic mutant, indicating the critical role of Sip2 acetylation
in life span modulation. We further investigated glucose limita-
tion, peroxide sensitivity, and age-associated changes in Sip2
acetylation, established the role of Sip2 acetylation in controlling
Snf1 interactions and activities. Finally, we established that
Sch9, the yeast homolog of Akt and S6K (Madia et al., 2009),
was a common downstream target of two distinct replicative
life span regulating pathways: the intrinsic aging defense
pathway described here controlled by Snf1 kinase and the
extrinsic nutrient-sensing pathway regulated by TORC1.
RESULTS
Sip2 Acetylation Is Controlled by NuA4 and Rpd3
To investigate the function of Sip2 acetylation, we identified four
acetylated lysine residues (K12, K16, K17, and K256) (Figure 1A),
using tandem mass spectrometry (Figures S1A–S1C available
online). We then created unacetylable lysine-to-arginine mutant970 Cell 146, 969–979, September 16, 2011 ª2011 Elsevier Inc.constructs at these four sites in various combinations by site-
directed mutagenesis and introduced these mutant SIP2
constructs into the endogenous chromosomal locus (Toulmay
and Schneiter, 2006). Using a previously described reverse IP
approach (Lin et al., 2009), we showed that Sip2 is hypoacety-
lated when the first three (K12, K16, and K17 [3KR]) or all
four (K12, K16, K17, and K256 [4KR]) lysines are mutated
(Sip2-3KR or -4KR; Figures S1D, Figure 1B). We also created
a chromosomally integrated SIP2 glycine 2-to-alanine mutant
(sip2-G2A) to mimic the short-lived, non-N-myristoylated
species of Sip2 (Ashrafi et al., 2000). We found that sip2-G2A
did not have acetylation defects (Figure 1B). An in vitro deacety-
lation reaction carried out with purified Rpd3-TAP and Hda1-
TAP (Figure S2A) revealed that Rpd3 treatment abolished the
acetylation signal of Sip2 (Figure 1C). We demonstrated the
activity of purified Hda1-TAP by showing that it deacetylated
lysine 14 of FLAG-Htz1 purified from hda1D strain (Figure S2B)
(Lin et al., 2008). As will be shown below, mutagenesis of the
Sip2 acetylation sites affects replicative aging. The findings are
consistent with a previous report that Rpd3, but not Hda1, is
involved in replicative life span regulation (Kim et al., 1999).
Previously we have shown that the acetylation signals of Sip2
are virtually completely dependent on NuA4/Esa1 both in vivo
and in vitro (Lin et al., 2009). Importantly, simultaneous deletion
AC D
B Figure 2. Sip2 Acetylation Increases the
Cellular Replicative Life Span
(A) Survival curves of the indicated strains with
each median life span in parentheses. The frac-
tions of live cells are plotted as a function of age in
generations. Strains carrying esa1-531 exhibit life
span shortening that is rescued by SIP2 acetyla-
tion mimetics (sip2-3KQ and sip2-4KQ).
(B) Deletion of RPD3 reverses the short life span of
esa1-531.
(C) sip2-4KR mutants, as well as the sip2-G2A
mutants and deletion of SIP2, decrease cellular life
span,whereas sip2-4KQmutants increase life span.
(D) Simultaneous sip2-4KQ mutants on the back-
ground of rpd3D fail to further increase life span of
rpd3D. Statistical significance was determined by
Mantel-Cox log-rank test and the details are pre-
sented in Table S1.of RPD3 reversed the hypoacetylation caused by NuA4 catalytic
subunit temperature-sensitive (Ts) allele esa1-531 when cells
were shifted to the nonpermissive temperature (Figure 1D).
Further, the increased acetylation in rpd3D was abolished by
sip2-3KR and -4KRmutations (Figure 1E). These results support
the simple hypothesis that K12, K16, K17, and K256 in Sip2 are
acetylated by Esa1 and are deacetylated by Rpd3.
Sip2 Acetylation Mimetics Increase Replicative Life
Span
We next examined replicative life span of the SIP2 acetylation
mutants (refer to Table S1 for detailed statistical results). We
found that the esa1-531 strain showed a shortened replicative
life span when grown at a semipermissive temperature, 30C.
Importantly, in an esa1-531 strain, the lysine-to-glutamine
mutants of SIP2 (sip2-3KQ and sip2-4KQ), mimicking acetylated
Sip2, reversed the shortened life span of esa1-531 (Figure 2A).
Consistent with the above findings, deletion of RPD3 also
reversed the shortened life span of esa1-531 (Figure 2B). We
also found that sip2-4KQ significantly increased the life span,
whereas sip2-4KR and sip2D strains decreased life span to
a similar extent when compared to wild-type (WT) SIP2+ strains
(Figure 2C). Because the N-myristoylation on glycine 2 of Sip2 is
essential for long life span (Ashrafi et al., 2000; Lin et al., 2003),
the chromosomally integrated sip2-G2A mutant was used as
a positive control for shortened life span (Figure 2C). Finally,
we confirmed that simultaneous sip2-4KQmutant did not further
extend the life span of the null mutant ofRPD3 (Figure 2D). These
results provide strong evidence supporting Sip2 as the critical
downstream target of Esa1 and Rpd3 in regulating replicative
life span in yeast.
Sip2 Acetylation and Calorie Restriction
Because carbon substitutions greatly influence longevity in yeast
(Barker et al., 1999; Kaeberlein et al., 2005), we next askedCell 146, 969–979, Sewhether different carbon sources affect
Sip2 acetylation status. We monitored
Sip2 acetylation (Ac-Sip2) levels after
treating cells with 2% glucose, 2% galac-tose, 0.05% glucose, or 2% glycerol plus 3% ethanol. The only
significant difference in acetylation states was observed when
cells were treated with 0.05% glucose (low glucose, LG);
although Sip2 protein abundance was upregulated, the acetyla-
tion signal decreased significantly (Figures S3A and S3B). This
contradicts a simple model that calorie restriction extends
replicative life span via Sip2 acetylation. Indeed, calorie restric-
tion was shown to increase replicative life span through Sir2
(Lin et al., 2002) and other mechanisms (Kaeberlein et al.,
2005).We therefore examinedwhether low glucose (LG) affected
life span in the SIP2 acetylation mutants and found that LG,
when compared to 2% glucose (normal glucose, NG), increased
life span by 50% in the sip2-4KR and sip2D strains and, to
somewhat a lesser extent, in WT (30%) (Figures 3A–3C and
Table S1). However, LG failed to significantly increase the life
span of the sip2-4KQmutant (Figure 3D and Table S1). Because
glucose limitation significantly improved the replicative life
span of sip2-4KR and sip2D, these findings imply that calorie
restriction extends life span through a mechanism largely inde-
pendent of Sip2 acetylation. The fact that calorie restriction failed
to significantly extend the life span of sip2-4KQ, which was
similar to that reported in rpd3D (Jiang et al., 2002), suggests
the existence of a common effector(s) downstream of the Sip2
acetylation and calorie restriction modulating replicative life
span in yeast.
Aging Decreases Sip2 Acetylation and Interaction
with Snf1
To investigate the effect of replicative aging on Sip2 acetylation,
we examined Ac-Sip2 in young and old cells by sorting biotin-
labeled mother cells (Smeal et al., 1996). The sorting efficiency
was confirmed by showing that old cells contained a mean of
seven bud scars, whereas young cells had none (Figure S3C).
We found that Ac-Sip2 levels decreased in old cells (Figure 4A).
Coimmunoprecipitation of Sip2-TAP and Snf1-HA demonstratedptember 16, 2011 ª2011 Elsevier Inc. 971
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Figure 3. Glucose Limitation and Replica-
tive Life Span in SIP2 Acetylation Mutants
Survival curves of WT (A), sip2D (B), sip2-4KR (C),
and sip2-4KQ (D) grown in normal (2%, NG) versus
low glucose (0.05%, LG) media. The fractions of
live cells are plotted as a function of age in
generations. Median life span is shown in paren-
theses. Glucose limitation significantly increases
life span in WT, sip2D, and sip2-4KR, but not in
sip2-4KQ, as determined by Mantel-Cox log-rank
test. The statistical results were summarized in
Table S1. See also Figure S3.that, although the interaction between Sip2 and Snf1 was readily
seen in young cells, it became undetectable in old cells
(Figure 4B).
To determine whether Sip2 acetylation dictates physical inter-
action between Sip2 and Snf1, we examined their association in
SIP2 acetylation mutants. Physical interaction between Sip2 and
Snf1 significantly decreased in esa1-531 but increased in rpd3D
(Figure 4C). More importantly, whereas the sip2-3KR and
sip2-4KR mutations almost abolished the interaction with Snf1,
the sip2-3KQ and sip2-4KQ mutations markedly enhanced it
(Figure 4D), supporting the idea Sip2 acetylation is required for
Snf1 interaction and defining the N terminus of Sip2 as an
enhancer of Snf1 interaction (Figure 1A). In contrast, the myris-
toylation null mutation sip2-G2A (Lin et al., 2003) did not affect
the physical interaction between Sip2 and Snf1 (Figure 4D), sug-
gesting that myristoylation regulates Snf1 activity via a different
mechanism. Because Sip2 is a negative regulator of Snf1 (Ash-
rafi et al., 2000), these results at least partially explain why
Snf1 activity, which is stimulated under carbon stress, increases
with age and hence has detrimental effects on life span, even in
the presence of abundant ambient glucose (Lin et al., 2003).
To establish the connection between aging and Sip2 acetyla-
tion status in cells, we measured trehalose levels, a general
stress indicator in yeast, in young and old cells. This is based
on the previous findings that, during the quiescent phase, treha-
lose is stored in favor of glycogen presumably to fulfill its nu-
merous stress-protectant functions (Shi et al., 2010). Indeed,
we found that young cells contained significantly less trehalose
than old cells (Figure 4E). Glucose limitation, a form of nutrient
stress, also significantly increased trehalose levels as reported
before (Figure S3D) (Pluskal et al., 2011). Measurement of treha-
lose levels revealed that esa1-531 contained elevated trehalose
levels that were partially reversed by concomitant RPD3 deletion
(Figure S3E). Sip2-4KR rpd3D and sip2D rpd3D increased treha-972 Cell 146, 969–979, September 16, 2011 ª2011 Elsevier Inc.lose levels compared to rpd3D (Fig-
ure S3F). Also, sip2-4KR, sip2-G2A, and
sip2D mutants had increased trehalose
levels compared to WT, whereas sip2-
4KQ had a lower level of trehalose (Fig-
ure 4F), supporting a role of Ac-Sip2 in
counteracting stress. We further showed
that sip2-4KR and sip2D mutants were
much more sensitive to hydrogen per-
oxide (H2O2), a form of oxidative stressand a mediator of aging (Giorgio et al., 2007), when compared
to WT (Figure 4G); on the contrary, sip2-4KQ was resistant to
H2O2 (Figure 4G).
Consistent with previous findings that trehalose plays a key
role in fueling cell-cycle progression during growth and division
(Shi et al., 2010), we found that growth rates significantly
decreased in the rpd3D strain (Figure S4A) and the sip2-4KQ
strain on various genetic backgrounds (Figures S4B and S4C).
Conversely, sip2-4KR and sip2D mutants partially rescued the
rpd3D growth defect (Figure S4A). Cell volumes were similarly
affected by the mutations; all of the slower-growing variants
were smaller than normal cells (Figure S4D).
Sch9 Is the Downstream Target of Sip2-Snf1
Based on the above results and literature information, we
proposed that Snf1 might have a downstream target that,
when phosphorylated by Snf1, fuels rapid cell growth but results
in shortened life span. In a previous phosphorylation proteome
microarray study, 80 in vitro Snf1 substrates were identified (Pta-
cek et al., 2005). Among these, Sch9 (an Akt/S6K homolog)
kinase was a promising candidate because it had already been
shown to play an important role in yeast aging (Kaeberlein
et al., 2005). In addition to Snf1, Sch9 is the in vitro substrate
of two additional kinases (of 87 kinases tested): Tos3, the
upstream kinase of Snf1 (Kim et al., 2005) and Pho85 (Ptacek
et al., 2005). Sch9 is also a well-known in vivo kinase substrate
of target of rapamycin complex 1 (TORC1). Similar to TORC1,
it negatively regulates life span in response to nutrient availability
(Kaeberlein et al., 2005; Urban et al., 2007). A kinase itself, Sch9
phosphorylates a critically important ribosomal protein, Rps6
(Urban et al., 2007); rps6D mutants grow slowly and are small,
but they have increased replicative life span through general
inhibition of translation machinery (Chiocchetti et al., 2007) and
protein synthesis (Huber et al., 2009).
Young Old
A
IP
Input
IgG HC
Sip2-TAP
E
0.0
2.5
5.0
7.5
10.0
12.5
Tr
eh
al
os
e
G0 G7
B Young Old
IP: TAP
α -HA
Input:
α-Sip2-TAP
Input:
α-Snf1-HA
C WT esa1 rpd3Δ
IP: TAP
α -HA
IP: α-Ac-K; input: α-TAP
Input:
α-Snf1-HA
Input:
α-Sip2-TAP
D
IP: TAP
α -HA
Input:
α-Sip2-TAP
Input:
α-Snf1-HA
α-Tubulin
Sip2-TAP
Snf1-HA
WT
sip2-
3KR
sip2-
4KR
sip2-
G2A
sip2-
3KQ
sip2-
4KQ
-
-
+ +
+ + +
+ +
+ +
+ +
+ +
+
0
1
2
3
Tr
eh
al
os
e
F
*
0.001
0.01
0.1
1
10
Fr
ac
o
n
su
rv
iv
al
G
H2O2
** ***ns
60 min
0 min
Figure 4. Sip2 Acetylation and Physical Interaction between Sip2 and Snf1 Decrease as Cells Age
(A) Sip2 acetylation is significantly decreased in old cells.
(B andC) Physical interaction between Sip2 and Snf1 assessed by coimmunoprecipitation is decreased in old cells (B) and esa1-531 strain but increased in rpd3D
strain (C).
(D) Interaction between Sip2 and Snf1 is decreased in sip2D, and deacetylation mimetics (sip2-3KR and sip2-4KR) but is not changed in sip2-G2A mutants.
The interaction significantly increases in acetylation mimetics (sip2-3KQ and sip2-4KQ mutants).
(E) Cellular trehalose is significantly increased when cells age. Error bars show standard error of the mean. n = 3.
(F) Trehalose levels are significantly higher in sip2-4KR, sip2-G2A, and sip2Dwhen compared toWT but are lower in sip2-4KQ. Error bars show standard error of
the mean. n = 3.
(G) Fractions of survival of WT, sip2-4KR, sip2-4KQ, and sip2D before and after 1 hr of treatment with 1.5 mM H2O2, are plotted on a log scale. Error bars
show standard error of the mean. n = 2. Statistical significance was assessed by two-way ANOVA with post-hoc test. ns, nonsignificant; *p < 0.05; **p < 0.01;
***p < 0.001.
See also Figure S3 and Figure S4.We first showed that Sch9 is an in vitro and in vivo substrate of
Snf1. We purified GST-Sch9 and assessed the phosphorylation
signal by performing immunoblotting with antiphosphoserine
and antiphosphothreonine antibodies (Jablonowski et al.,
2004). As a proof of concept, the signal of phosphorylated
GST-Sch9 nearly totally disappeared after treatment with calf
intestine phosphatase, whereas sodium pervanadate (a phos-
phatase inhibitor) restored the phosphorylation signal (Fig-
ure S5A). We carried out an in vitro kinase assay with purified
Snf1-TAP (Figure S2A) from a sip2D strain and showed serine
and threonine phosphorylation of GST-Sch9 in vitro by Snf1
kinase (Figure 5A). We further confirmed that endogenousSch9-HA phosphorylation markedly decreased in snf1D espe-
cially after treatment with rapamycin to block TORC1 activity
(Figure 5B and whole gel images in Figure S5B). Moreover, a
mutation that abolishes the kinase activity of Snf1 (snf1-K84R)
fails to revert the decreased phosphorylation of endogenous
Sch9-HA in a snf1D strain (Figure S5C), which suggests that
Sch9 is a bona fide in vivo substrate of Snf1.
To detect Sch9 phosphorylation states in different SIP2
mutants, we purified GST-Sch9 proteins from WT, sip2-4KR,
sip2-4KQ, and sip2D strains and assessed their phosphorylation
signals. Both serine and threonine phosphorylation increased
slightly in sip2-4KR and sip2D compared to WT and sip2-4KQCell 146, 969–979, September 16, 2011 ª2011 Elsevier Inc. 973
A
GST-Sch9
Snf1
ATP
α-P-Ser
α-P-Thr
α-GST
- -
- -
+ +
++
Young Old
D
Sch9-HA
IP: HA
α -P-Ser
IP: HA
α -P-Thr
α -HA
B
Rapa
WT snf1Δ WT snf1Δ
Sch9-HA
- + +
IP: HA
α -P-Ser
IP: HA
α -P-Thr
α-Tubulin
α -HA
In vitroC
WT sip2-
4KQ
sip2Δ
GST-Sch9 (+ Rapamycin)
sip2-
4KR
In vivo
α-P-Ser
α-P-Thr
α-GST
-
sch9Δ
0 25 50 75 100
0.0
0.2
0.4
0.6
0.8
1.0F
sip2Δ sch9Δ (43.5)
sip2-4KR sch9Δ (43)
sch9Δ (51.5)
WT (24)YPD
WT
sch9Δ
sip2-4KR
sch9Δ 
sip2 Δ
YPD + RapamycinE
Figure 5. Acetylation of Sip2 Affects Snf1 Kinase Activity and Results in Hypophosphorylation of Sch9
(A) Snf1 phosphorylates GST-Sch9 in vitro at both serine and threonine sites. In vitro kinase assays were performed by incubating purified GST-Sch9 with or
without Snf1 or ATP as indicated and analyzed by phosphoserine antibody (a-P-Ser) and phosphothreonine antibody (a-P-Thr) to detect Sch9p phosphorylation.
(B) Endogenous Sch9-HA phosphorylation decreases in snf1D mutants after rapamycin (200 ng/ml) treatment to suppress the TOR pathway. Arrowheads
indicate the Sch9-HA band.
(C) GST-Sch9 phosphorylation increases in sip2-4KR and sip2D but decreases in sip2-4KQ, compared to WT after rapamycin (200 ng/ml) treatment.
(D) Endogenous Sch9-HA phosphorylation significantly increases in the old cells. Arrowheads indicate the Sch9-HA band.
(E) SCH9 is epistatic and thus downstream to SIP2 in regulating cellular growth. Ten-fold dilutions of the indicated strains were spotted and grown on YPD plates
without (2 days, 30C) or with rapamycin (25 ng/ml, 4 days, 30C).
(F) Deletion of SCH9 rescues the life span shortening of sip2D and sip2-4KR.
See also Figures S1 and Figure S5.(Figure S5D); the differences were enhanced by inhibiting
TORC1 with rapamycin (Figure 5C), with the lowest level of
phosphorylation observed in the sip2-4KQ mutant. Finally, we
confirmed that endogenous Sch9-HA phosphorylation markedly
increased as cells aged (Figure 5D), which is consistent with
aging-associated increase in Snf1 kinase activity.
To demonstrate that Sch9 is the critical downstream mediator
of Sip2 in regulating growth and life span, we analyzed epistasis.
The growth defects of sch9D cells were not rescued by sip2-4KR
and sip2D (Figure S5E) as expected for a downstream effector.
We showed that sch9D was hypersensitive to rapamycin as
reported (Urban et al., 2007), which remained unaltered in the
concomitant SIP2 mutants (Figure 5E). We also observed that
the phenotype of shortened life span in the sip2D and sip2-4KR
mutant cells was nearly completely reversed by deleting SCH9
(sip2D sch9D and sip2-4KR sch9D in Figure 5F). Consistent
with these observations, sch9D cells also showed comparable
life span extension to both double-mutant strains (Figure 5F).
These data support Sch9 as the downstream target of Sip2-Snf1.974 Cell 146, 969–979, September 16, 2011 ª2011 Elsevier Inc.Sip2-Snf1 and TORC1 Function in Parallel Upstream
of Sch9
By comparing growth patterns of Sip2 acetylation mutants in
YPD and rapamycin, we further examined whether Sip2-Snf1
and TORC1 function in parallel upstream of Sch9 in regulating
growth. Both rpd3D and sip2-4KQ showed growth defects in
YPD, consistent with reduced Sch9 activity in these mutants.
The growth differences among the mutants and WT were damp-
ened by rapamycin treatment (Figures 6A–6C) through sup-
pressing TORC1, an essential activator of Sch9; rapamycin did
not further inhibit growth of the already Sch9-suppressed
rpd3D and sip2-4KQ. Both sip2-4KR and sip2D partially rescued
the growth defects of rpd3D, possibly through Snf1 activation of
the downstream Sch9. Again, the growth differences disap-
peared when treated by rapamycin. In contrast, the growth
defects of rpd3D were not rescued by sip2-G2A, another
short-lived mutant (Figure S6A).
Sip2-Snf1 and TORC1 might similarly function in parallel
upstream of Sch9 to regulate replicative life span. We first
AC D
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Figure 6. Sch9 Is a Parallel Downstream Target of TORC1 and Sip2-Snf1
(A–C) Comparison of growth in YPD with and without rapamycin to reveal genetic interactions between RPD3 and SIP2. Ten-fold dilutions of the indicated strains
were spotted and grown on YPD plates without (2 days, 30C) or with rapamycin (25 ng/ml, 4 days, 30C).
(D) The life span of sip2-4KR and sip2D in rapamycin is shorter than that of WT in rapamycin (25 ng/ml).
See also Figure S6.confirmed that rapamycin increased life span of WT (Figure S6B)
(Kaeberlein et al., 2005). We further showed that life span of
sip2-4KR and sip2D, although mildly increased after rapamycin
treatment (Figures S6C and S6D), remained significantly shorter
than WT in rapamycin, suggesting the importance of Sip2 acet-
ylation in controlling cellular life span independent of TORC1
activity (Figure 6D). Life span of sip2-4KQ and rpd3D were not
extended by rapamycin treatment (Figure S6E), consistent with
the fact that Sch9 serves as a common downstream effector.
These results support a protein acetylation/phosphorylation
signaling cascade distinct from the one mediated by TORC1
regulating cellular growth and life span through Sch9 as the
common kinase effector.
Finally, we showed that SCH9 mutants of seven known PDK
(phosphoinositide-dependent protein kinase)-dependent and
TORC1-dependent phosphorylation sites (Urban et al., 2007) still
showed increased phosphorylation signal upon treatment with
Snf1 kinase (Figure S6F), supporting the hypothesis that Snf1
catalyzes Sch9 phosphorylation at sites distinct from those
used by PDK and TORC1. These results also corroborate our
previous findings (Figure 3F) that glucose limitation and Sip2
acetylation seem to operate on the same effector protein in
affecting replicative life span.
DISCUSSION
Yeast longevity studies have provided instructive models for
understanding basic cellular processes in human aging (Bitter-
man et al., 2003). Among the conserved longevity pathways,acetyltransferase and deacetylases are well established as links
between cell metabolism, growth, and aging processes (Chang
and Min, 2002; Nakamura et al., 2010). Similar to their opposite
effects on chromatin silencing (Rundlett et al., 1996; Zhou
et al., 2009), mutations in deacetylases RPD3 and SIR2 showed
disparities in extending replicative life span previously thought to
be related to distinct histone tail targets (Chang and Min, 2002).
However, although histone acetylation changes do occur in
aging yeast cells, specific histone acetylation site mutants,
such as those of H4K16 and H3K56, do not phenocopy the
effects of the corresponding acetyltransferases and deacety-
lases on life span regulation (Dang et al., 2009; Ehrentraut
et al., 2010). This suggests a role for critical nonhistone acetyla-
tion substrates in life span regulation (Close et al., 2010).
We report here an in-depth replicative life span analysis of a
nonhistone substrate, Sip2, a b-regulatory subunit of yeast
AMPK (Snf1 complex) that was previously identified in a large-
scale proteomic screen of NuA4 acetyltransferase (Lin et al.,
2009). Four functionally important acetylation sites were identi-
fied; one falls within the C-terminal half within a region of Sip2
that was previously cocrystallized in a heterotrimer with Snf1
and its g subunit (Amodeo et al., 2007). The remaining three sites
cluster in the N terminus in a region absent from the structure
(and not phylogenetically conserved). Becausemutation of these
three lysines is sufficient to confer most of the interaction, life
span, and other phenotypes observed in vivo, we suggest that
Sip2 N-terminal acetylation might change Sip2 conformation,
allowing binding to Snf1 and/or the g subunit to stabilize the
Sip2-Snf1 complex.Cell 146, 969–979, September 16, 2011 ª2011 Elsevier Inc. 975
Figure 7. Model for the Effects of Sip2 Acetylation on Life Span
Regulation
Red lines indicate the intrinsic aging defense pathway identified in this study.
Blue lines indicate the extrinsic nutrient-sensing pathway regulating Sch9
activity. Not shown here for clarity is evidence of a connection between the two
pathways in that we also observed a modest decrease in Sip2 acetylation in
glucose limitation. Ac, lysine acetylation; DeAc, lysine deacetylation; Ph,
phosphorylation of serine and threonine.NuA4 acetyltransferase, along with the corresponding Sip2
deacetylase Rpd3, are directly involved in replicative life span
regulation. Not only did Sip2 acetylation-mimic mutants live
significantly longer, they nearly totally rescued the severely
shortened life span of NuA4 catalytic mutants. This life span
extension validates their importance as key substrates regu-
lating aging. Furthermore, unacetylable Sip2 mutants, like a
complete deletion, led to a shortened life span compared to
WT, further supporting the critical role of Sip2 acetylation in
Sip2 function. The fact that Sip2 (de)acetylationmimetics pheno-
copy the corresponding catalytic mutants of NuA4 and Rpd3
strongly supports the importance of Sip2 as the critical down-
stream nonhistone substrate of these enzymes in controlling
replicative life span.
Sip2 is a regulatory subunit of the Snf1 complex that is homol-
ogous to the AMPK complex in higher organisms and plays a
critical role in metabolism and other cellular processes in
response to energy supply (Scott et al., 2009). As a key regulator
of energy homeostasis controlled by AMP/ATP ratios and
various upstream kinases (Lee et al., 2007; Sanz, 2008), we
show here that Snf1 kinase activity can be independently
controlled by acetylation of Sip2. These findings help interpret
the fact that Snf1, required for transcription of glucose-re-
pressed genes (Hedbacker and Carlson, 2008) and a key player
in response to cellular stress (Sanz, 2003), exhibits increased
activity with aging and detrimental effects on life span (Lin
et al., 2003). Our results suggest that Sip2 acetylation enhances
physical interaction with Snf1 and thereby antagonizes catalytic
activity. An increase in the disaccharide trehalose is observed as
a common response to glucose limitation and replicative aging,
representing two distinct stressors in yeast (Shi et al., 2010;
Wang et al., 2010). Decreased Sip2 acetylation observed in
these distinct stress conditions helps explain increased Snf1976 Cell 146, 969–979, September 16, 2011 ª2011 Elsevier Inc.activity. The antagonistic effect of Sip2 acetylation on Snf1
activity explains how Sip2 suppresses the detrimental effects
of Snf1 on replicative life span extension (Lin et al., 2003).
Hydrogen peroxide (H2O2), yet another form of stress and aging
mediator, accumulates as aging occurs (Giorgio et al., 2005;
Migliaccio et al., 1999). We showed here that Sip2 acetylation
was critical for H2O2 resistance, supporting the hypothesis that
Sip2 acetylation protects yeast cells from oxidative stress.
Through in vitro and in vivo kinase assays and epistasis
analyses, we confirmed that Sch9, the yeast homolog of
mammalian Akt/S6K (Powers, 2007), is a critical downstream
effector of both TORC1 (Kaeberlein et al., 2005) and the Snf1
complex. In addition to being boosted by sensing nutrient acces-
sibility via TORC1, we observed that Sch9 can be independently
phosphorylated and activated by the Snf1 kinase. This age-
dependent regulation of Snf1 kinase activity is governed by
progressive deacetylation of Sip2, which releases Snf1 from
Sip2 inhibition in old cells. However, it is possible that this pro-
gression is only one dimension of this regulatory pathway and
that there might be dynamic changes in Sip2 acetylation state
in response to certain stresses in younger cells. The Snf1-medi-
ated phosphorylation and activation of Sch9 associated with
replicative aging processes might ultimately lead to dysregu-
lated protein homeostasis, representing a type of ‘‘intrinsic
aging.’’ Intrinsic agingmight represent exhaustion of ametabolite
or regulatory factor or the unavoidable accumulation of damage
(proteotoxicity, oxidative, metabolic, DNA damage, etc.) during
aging (Cohen and Dillin, 2008; Haigis and Yankner, 2010; Silva
and Conboy, 2008; Vijg and Campisi, 2008). This intrinsic aging
is counteracted by a series of posttranslational modifications
on several critical enzymes that works in parallel to an ‘‘extrinsic
nutrient-sensing pathway’’ through common downstream
machinery to coordinate vegetative growth and replicative life
span in the yeast cells (Figure 7).
AMPK activation promotes longevity under calorie restriction
in metazoans (Evans et al., 2011; Mair et al., 2011; Williams
et al., 2009). The finding that AMPK in yeast seemingly plays an
opposite role to that observed previously in metazoans is
intriguing. However, AMPK activity has also been found to
increase during senescence in various cellular models, including
fibroblasts (Wang et al., 2003), skeletal muscle cells (Thomson
et al., 2009), and aortic endothelial cells (Zu et al., 2010). Although
transient activation of AMPK protects cells against various
internal and external stresses (Narbonne and Roy, 2009), pro-
longed activation of AMPK is paradoxically correlated with
irreversible senescence and has detrimental effects on normal
physiological functions in mammalian cells (Jones et al., 2005;
Marin˜o et al., 2008; Wang et al., 2011). Also, in a normal mouse
brain, AMPK activity increased with age (Liu et al., 2011). These
findings on senescent mammalian cells may be related to the
‘‘end-stage’’ phenotype observed in old yeast mother cells.
The acetylation-phosphorylation signaling cascade is largely
independent of calorie restriction but could potentially integrate
information of ambient nutrient availability and intracellular meta-
bolic status through Sch9, a major downstream substrate of
TORC1 kinase. Whether calorie restriction is the only means of
life span extension remains a debated issue (Colman and Ander-
son, 2011). Previous reports suggest that calorie restriction
might lead to unwelcome health concerns, especially in elderly
and nonobese subjects (Dirks and Leeuwenburgh, 2006). Thus
modulators of the intrinsic aging might represent more attractive
pharmacologic candidates than calorie restriction mimetics
for life span extension. Although details might differ between
yeast and metazoans, we note that a similar signaling cascade
potentially exists in higher organisms because all of the major
components are evolutionarily conserved.EXPERIMENTAL PROCEDURES
Strains and Plasmids
Yeast strains used in this study are derived fromBY4741 (MATa his3D1 leu2D0
met15D0 ura3D0) and listed in Table S2. Integrated site-directed mutagenesis
was performed as previously described (Toulmay and Schneiter, 2006) and
verified by sequencing. The primers used for site-directed mutagenesis and
sequencing are listed in Table S3. Refer to the Extended Experimental Proce-
dures for mass spectrometer, in vivo acetylation, enzyme purification, and
in vitro deacetylation.
Replicative Life Span Determination and Statistical Analysis
Replicative life span was carried out as described (Kaeberlein et al., 1999). In
brief, cells were freshly streaked to YPD (1% yeast extract, 2% peptone, 2%
dextrose, and 2% agar) from glycerol stock and recovered at room tempera-
ture for 2 days and then lightly patched on a new YPD plate and grown over-
night. An appropriate number of individual cells was randomly picked under
a microscope and aligned in isolated areas with a micromanipulator. After
about 2 hr of incubation at 30C, virgin cells (newly budded cells) were sepa-
rated and left at the original site, and the mother cells were removed to the
grave yard. The life span of these cells was determined by counting the total
number of daughter cells produced. The old mother cells were defined dead
when the budding process stopped and the refractility was completely lost.
For life span analyses in low glucose (LG), cells were grown on YEP plate
(1% yeast extract, 2% peptone, 2% agar) containing 0.05% dextrose.
For life span analyses in rapamycin, cells were grown on YPD containing
25 ng/ml rapamycin. The nonparametric Mantel-Cox log-rank test was per-
formed usingGraphPad Prism (version 5.00 forWindows, GraphPad Software,
San Diego California USA) to assess statistical significance of life span differ-
ences, as listed in Table S1.
Sorting Old Cells
Yeast old mother cells (generation 7, G7) were isolated from young cells
(generation 0, G0) as described (Smeal et al., 1996). In brief, fresh cells were
grown at 24C in YPD (1% yeast extract, 2% peptone, and 2% dextrose) to
an A600 of0.6, and then 10 A600 units of the cells was labeledwith 7mg freshly
prepared biotin (EZ-link Sulfo-NHS-LC-LC; Pierce), cultured to 1 L YPD from
A600 0.01 to A600 0.8 at 24
C in YPD, followed by affinity purification using
Dynabeads MyOne and DynaMag-50 (Invitrogen) according to the manufac-
turer’s suggestions. An aliquot of sorted cells was stained with 0.1 mg/ml
Calcofluor White (Sigma-Aldrich, F3543) and observed using a Zeiss Axioskop
fluorescent microscope equipped with a Cool Snap FX camera for bud scar
counting.
Trehalose Assay
A trehalose assay was performed as previously described (Shi et al., 2010). In
brief, 10 A600 units of cells grown in synthetic dropout media to exactly A600 1.2
were pelleted and quickly washed with 1.2 ml ice-cold H2O and then resus-
pended in 0.3 ml 0.25 M Na2CO3. The samples were boiled for 4 hr, and
then 0.18 ml of 1 M acetic acid and 0.72 ml of 0.2 M sodium acetate was
added to each sample. For controls, half (0.6 ml) of each sample was trans-
ferred to a microfuge tube, and the remaining half (0.6 ml) of the sample was
incubated overnight with 0.025 U/ml trehalase (Sigma-Aldrich, T8778) at
37C. Samples were then centrifuged at top speed for 3 min and assayed
for glucose using a Glucose Assay Kit (Sigma-Aldrich, GAGO20).H2O2 Stress Tolerance Test
The test was performed as previously described (Jamieson, 1992) with slight
modification. Exponential phase cultures of WT, sip2-4KR, sip2-4KQ, and
sip2D strains growing at 30C in YPD (A600 0.25, equals to 5.4 3 10
6 per ml)
were divided into two aliquots (duplicated) and treated for 1 hr at 30C with
1.5 mM H2O2. About 200 cells were placed on YPD plates before (0 min)
and after (60 min) H2O2 treatment. Number of colonies formed was counted
after overnight culture at 30C. Fraction of survival was calculated by dividing
the number of colonies formed after H2O2 treatment by the number before
treatment, with the fraction of survival of each strain before treatment being
set as 1. Statistical significance was assessed by two-way ANOVA plus
post-hoc tests. Refer to Extended Experimental Procedures for cell size
determination.
In Vitro Kinase Assay
Snf1-TAP in a sip2D strain was purified as described (Puig et al., 2001). Kinase
reactions were done in kinase buffer (25 mM HEPES [pH 7.5], 10 mM MgCl2,
2 mM DTT, 0.1 mM EDTA, 0.1 mM EGTA, 50 mM KCl, with or without 1 mM
ATP) for 30 min at 30C using 1 mg substrate and 100 ng Snf1-TAP.
Reactions were stopped by boiling in 23 SDS sample buffer and then sepa-
rated by SDS-PAGE. Phosphorylation signals were assessed by immunoblot
blotting using phosphoserine antibody (QIAGEN, 37430) and phosphothreo-
nine antibody (QIAGEN, 37420) following essentially the manufacturer’s
manual as described (Jablonowski et al., 2004). To verify that the antibodies
are phosphorylation specific, GST-Sch9 purified from WT was treated with
calf intestinal alkaline phosphatase (New England Biolabs, M0290S) following
the manufacturer’s protocol, with or without adding Na3VO4 (Sigma-Aldrich,
S6508), a phosphatase inhibitor. Reactions were separated by SDS-PAGE
and probed with phosphoserine and phosphothreonine antibodies as
described above. In vitro kinase assay using GST-Sch9 mutated at four serine
or three threonine phosphorylation sites previously identified as PDK and
TORC1 targets (Urban et al., 2007) was performed to test whether these sites
were Snf1 targets. Refer to Extended Experimental Procedures for in vivo Sch9
phosphorylation.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures,
six figures, and three tables and can be found with this article online at
doi:10.1016/j.cell.2011.07.044.
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